Wird geladen...
Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLC). Notably, new molecular profiling technologies have permitted dynamic growth in the identification of actionable driver oncogenes including RET rearrangements. RET on...
Gespeichert in:
| Veröffentlicht in: | Oncol Rev |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
PAGEPress Publications, Pavia, Italy
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065052/ https://ncbi.nlm.nih.gov/pubmed/30093982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2018.352 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|